Home > Boards > US OTC > Internet - Online Services >

Plural Industry Holding Group Co. Ltd. (PIHG)

PIHG RSS Feed
Add PIHG Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/9/2022 1:40:04 PM - Followers: 59 - Board type: Free - Posts Today: 0

EAIN

Enabling Asian Inc
 
Nevada SOS name change to  Mirror Biologics, Inc on 10/29/2020



https://www.fundable.com/mirror-biologics


Active Clinical Trial:
https://clinicaltrials.gov/ct2/show/NCT04441047?term=NCT04441047&draw=2&rank=1
 

Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults

https://www.prnewswire.com/il/news-releases/immunovative-therapies-and-mirror-biologics-announce-us-fda-clearance-of-a-universal-anti-viral-vaccine-phase-iii-clinical-trial-for-healthy-elderly-adults-301081793.html

JERUSALEM and PHOENIX, June 23, 2020 /PRNewswire/ -- Mirror Biologics, Inc. (Phoenix, AZ), the commercial development arm of Immunovative Therapies, Ltd. (Jerusalem, IL) (together "the Company"), a clinical-stage company specialized in the development, manufacturing and clinical translation of next-generation immunotherapy drugs where the active ingredients are living immune cells, today announced that the U.S. Food and Drug Administration (FDA) has cleared our Phase I/II universal virus vaccine clinical trial under the Company's second active Investigational New Drug (IND) application enabling use of the Company's lead experimental drug, AlloStim®, for testing as an anti-viral prophylaxis drug.

AlloStim® is an off-the-shelf, non-genetically manipulated, patented living immune cell with multiple immunodulatory properties, currently being tested under a separate IND as a therapeutic vaccine for chemotherapy-refractory metastatic cancers.

This Phase I/II trial is believed to be the first anti-viral vaccine in clinical development that is specifically targeted to protect the elderly. The elderly are the most vulnerable in our society to the severe and lethal effects of respiratory viral infections which cause disease complications such as pneumonia. Pneumonia is the single most common cause of death from infectious disease in those over 65 years old. The chance that a COVID-19 patient will develop symptoms severe enough to require hospitalization and  respiratory support rises sharply with age and the death rate due to COVID-19 is disproportionately higher in our senior citizens.

Dr. Michael Har-Noy, founder and CEO stated: "We are pleased to have FDA clearance of our novel universal viral vaccine clinical trial targeted to healthy adults over 65 years old. There is a large unmet need to protect the elderly from the devastating effects of respiratory viral infection. If we can protect the elderly from COVID-19, economies can open safely and herd immunity can be allowed to develop without an alarming increase in death rate. Even if a COVID-19 vaccine is developed, it is likely, as with influenza vaccines, that it will be less effective in the elderly where protection is most needed. In addition, a successful COVID-19 vaccine is vulnerable to weakening upon mutation of the virus and will not protect against future novel viral outbreaks. Our universal vaccine technology is designed to protect against any type of viral infection without the requirement to have prior knowledge of the viral structure and is specifically designed to work in the weakened senescent immune systems of the elderly and frail."

The Phase I/II clinical trial will accrue 40 healthy adults over age 65. Volunteers will receive five (5) intradermal injections of AlloStim® over 14 days. Blood samples will be collected prior to injection and at 30 days, 6 months and 1 year after injection. The blood will be challenged in the laboratory with a panel of live viruses, including the COVID-19 virus and influenza viruses in order to determine if the remodeled immune system can suppress the propagation of these viruses in cultures of human endothelial cells from the respiratory tract.

Details of the clinical trial can be found on the National Institutes of Health ClinicalTrials.gov registry: ClinicalTrials.gov Identifier: NCT04441047

The universal viral protection mechanism has been reversed engineered from the immune response that results in asymptomatic viral clearance in youthful individuals. Using a novel, patent-pending technology called "allo-priming", the youthful immune response is imprinted upon the elderly immune system so that it can be ready to be activated upon encounter with any virus. The mechanism creates conditions for an "in-situ" vaccine providing viral-specific protection and memory to prevent re-infection from the same virus. The novel mechanism has been described in a peer-reviewed article published in the Journal of Translational Medicine which can be viewed by following this link.

AlloStim® is derived from precursor cells purified from the blood of healthy donors. The Company will be working to scale up and automate the production process in parallel with on-going clinical trials so that upon demonstration of safety and efficacy, the vaccine can be quickly scaled-up to quantities necessary to protect the elderly population. Today, there is estimated to be more than 46 million adults age 65 and older living in the USA.

Media Contact:

Dr. Michael Har-Noy
Phone: 1-760-216-7494
email: harnoy@immunovative.com

Related Images

Mirror Biologics
Mirror Biologics, Inc (Phoenix) is the commercial development arm of Immunovative Therapies, Ltd. (Israel)

Related Links

Website

SOURCE Immunovative Therapies, Ltd.

PIHG
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#4425   I know dude! The second guessing should be fink 05/09/22 01:40:04 PM
#4424   Rock n Roll fink!!!!!!!! splintered sunlight 05/09/22 12:28:15 PM
#4423   Amen. I come into $250k June 10th. It fink 05/09/22 12:11:58 PM
#4422   No f@cking joke. splintered sunlight 05/09/22 10:51:17 AM
#4421   You should have stayed away longer. fink 05/09/22 10:43:54 AM
#4420   I've been away for the last week or so. splintered sunlight 05/09/22 10:17:20 AM
#4419   Who fell on the sword and bought the fink 05/03/22 10:00:27 AM
#4418   PIHG now Pink Current. splintered sunlight 03/16/22 12:45:29 PM
#4417   Nw filing - 10Q splintered sunlight 03/13/22 06:14:42 PM
#4416   https://www.otcmarkets.com/otcapi/company/financial-report/323399/content 1 splintered sunlight 03/13/22 06:14:09 PM
#4415   PIHG...business plan from LinkedIn account...... Potse 03/09/22 08:46:54 PM
#4414   Thank you - I hope that's good. splintered sunlight 02/16/22 11:09:46 PM
#4413   Annual list filed on Silverfume today. New president/director, PennyStaIker 02/16/22 06:44:48 PM
#4412   I didn't't realize the float was so low. splintered sunlight 01/04/22 03:19:35 PM
#4411   Only 75k to be had in the float. fink 01/04/22 03:16:44 PM
#4410   Someone really did want those 400 shares. splintered sunlight 01/04/22 03:02:01 PM
#4409   A grand slap ain’t no small thing for fink 01/04/22 02:53:53 PM
#4408   I have some - this one goes way splintered sunlight 01/04/22 02:51:13 PM
#4407   Not even 250 shares, fink 01/04/22 02:47:40 PM
#4406   You still in this bad boy? splintered sunlight 01/04/22 02:26:25 PM
#4405   Hoping so - thanks splintered sunlight 10/04/21 09:13:11 AM
#4404   PIHG Pink Current tonight. fink 10/04/21 01:46:05 AM
#4403   I feel your pain. fink 10/01/21 10:02:14 AM
#4402   I have no idea why I bought this one. splintered sunlight 09/30/21 11:51:06 PM
#4401   I need more dry powder. fink 09/30/21 09:41:34 PM
#4400   Already at 1,300 and looking to add..... splintered sunlight 09/11/21 06:59:42 PM
#4399   PIHG(1.50)...increased position..... Potse 09/11/21 06:42:38 PM
#4398   Yes. Lazar sold out Feb 1st fink 09/11/21 10:52:38 AM
#4397   This has already been R/M'ed already I think. splintered sunlight 09/11/21 10:18:19 AM
#4396   Lazar drops R/M news snd you don’t have fink 09/10/21 08:11:58 PM
#4395   1,000 shares just prints at 1.5!!!!!!!! splintered sunlight 09/10/21 03:24:53 PM
#4394   Ah. I prolly shoulda look at T & Patrick Bateman 09/10/21 01:25:35 PM
#4393   LOL I responded to fink's post when he said splintered sunlight 09/10/21 01:17:31 PM
#4392   I guess I was just confused as you Patrick Bateman 09/10/21 01:13:27 PM
#4391   Not sure what you mean by What does splintered sunlight 09/10/21 12:43:18 PM
#4390   What does this trade as? There’s no volume Patrick Bateman 09/10/21 12:32:30 PM
#4389   I think it might do a $1+ easily. splintered sunlight 09/10/21 12:20:44 PM
#4388   Actually It went Yield Pink Limited but it splintered sunlight 09/10/21 10:42:53 AM
#4387   I see it went current today. fink 09/10/21 09:23:40 AM
#4386   I was up in Traverse City, MI earlier Imagineer66 08/31/21 02:13:25 PM
#4385   $PIHG filings to go current including attorney letter TheSummerMan 08/31/21 10:09:30 AM
#4384   Why isn't PIHG Pink Current? splintered sunlight 08/17/21 06:02:03 PM
#4383   I'm glad.................. splintered sunlight 07/28/21 08:42:43 AM
#4382   hahaha, that made me laugh in a good Renee 07/27/21 04:26:21 PM
#4381   Can you cross them a little tighter please. splintered sunlight 07/27/21 12:43:39 PM
#4380   Good thought. I'll keep my fingers crossed for Renee 06/09/21 07:09:51 PM
#4379   Looking for great things to happen!!!!! splintered sunlight 06/09/21 06:46:29 PM
#4378   Enabling Asia Inc., EAIN, changed to Plural Industry Renee 06/09/21 06:14:19 PM
#4377   CUSIP and symbol change to PIHG. TheSummerMan 06/09/21 01:10:21 PM
#4376   I so hope you become fabulously rich from EAIN. splintered sunlight 03/24/21 11:10:59 PM
PostSubject
Consent Preferences